Pear Bio uses computational biology to monitor tumor progression. Our platform uses 3D cell culture, live-cell assays and computer vision to track tumor response to therapy (including combination therapy) and discover predictive/resistance biomarkers. Our platform has been validated on fresh and viably frozen patient samples across 8 solid tumor types.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
Yes